LewyLIGHTNCT07602296
Evaluating How Red-light Therapy Applied to the Head Affects Symptoms, Daily Life, and Brain Activity in People With Dementia With Lewy Bodies
At risk: Primary completion moved at least 4 months later.
See at-risk trials from University Hospital, Strasbourg, France
Free. We email you which fields changed when ClinicalTrials.gov updates this record.
Record History
All 3 versions: 3 with changes below. See every version on ClinicalTrials.gov ↗
Notable Recruitment opened Show 5 more changesShow less
- Eligibility criteria expanded, about 25 words
- Primary and study completion dates pushed to May 2029
- Start date changed from estimate of Jun 2026 to Sep 16, 2026
- Study description expanded, about 17 words
- Site details revised
Notable Primary endpoint(s) modifiedv2 Show 4 more changesShow less
- Eligibility criteria shortened, about 17 words
- Interventions: no photobiomodulation using the medical device (Device), photobiomodulation using the medical device (Device) to LUCIOLE CAP (Device), LUCIOLE CAP (sham version) (Device)
- Study description expanded, about 451 words
- Study title expanded, about 13 words
- Study First Submitted
- Notable: the plan changed
Endpoints
Primary
Arms and interventions
The participants assigned to the active group will each receive an active LUCIOLE cap to be used at home twice daily for six months with the assistance of their caregiver. A minimum interval of four hours is required between the two daily sessions. Each session lasts for 32 minutes (including 24 minutes of active near-infrared red light and 8 minutes of cooling periods spaced throughout the session). The cap automatically turns off at the end of each session. The caregiver assists the participant in placing the cap on correctly, verifies that the cap works properly, and starts the session. All participants in the active group will undergo neuropsychological evaluations, clinical and neurological examinations, MRIs, and blood tests and at months 0, 3 and 6 of the study. Participants will also be evaluated at month 7, one month after the end of the photobiomodulation sessions, during which the same clinical, neurological and neuropsychological evaluations will be administered.
Participants in the sham group will follow the same PBM schedule as the participants in the active group: twice daily sessions of 32 minutes for six months (see active group description for more information) except they will use the sham LUCIOLE cap. The sham cap mimics the appearance, heating and operation of the active cap but does not deliver PBM. The only difference between the two versions is in the internal electronics and firmware modifications. The two versions can only be differentiated by their serial numbers. All participants in the study, as well as the research team, do not know which caps are active and which are sham. As in the active group, participants in the sham group will undergo neuropsychological evaluations, clinical and neurological examinations, MRIs, and blood tests and at months 0, 3 and 6 of the study. Participants will also be seen at month 7, one month after the end of the PBM sessions, for clinical, neurological and neuropsychological evaluations.
Devices: LUCIOLE CAP, LUCIOLE CAP (sham version)
Sites
1 site in 1 country
- Hôpitaux Universitaires de StrasbourgStrasbourg, France